Products |
CAS No. |
API Application |
Send Enquiry |
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yI)phenyl 1-4, 5, 6, 7-tetrahydro-1H-pyrazolo [3, 4-c] pyridine-3-carboxylic Acid Ethyl Ester. |
503614-91-3 |
APIXABAN |
|
(2 R, 3S) -2-[(IR) -1-[3,5-Bis(trifIuoromethyl) phenyl ] ethoxy]-3-(4-fluorophenly) Morpholine hydrochloride (APT07) |
171482-05-6 |
APREPITANT |
|
N-(2-chIoro-I-methyI-ethyIidene)- hydra2inecarboxyIic acid methyl ester |
155742-64-6 |
APREPITANT SIDE CHAIN |
|
(S)-I-(3-Ethoxy-4-methoxyphenyl)-2- (methylsulfonyl)ethylamine N-acetyl-L-leucine salt |
608141-43-1 |
APREMILAST |
|
4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3- oxazolidin-3- yl]phenyl]morpholin-3-one hydrochloride |
898543-06-1 |
RIVAROXABAN |
|
3-(3-TrifIuoromethyI phenyl) propanol |
78573-45-2 |
CINACALCET |
|
R-(+) -1- (I-Naphthyl) Ethylamine |
3886-70-2 |
CINACALCET |
|
N1-((1S,2R,4S)-2-Amino-4-(dimethylcarbamoyl)cyclohexyl)-N2-(5-chloropyridin-2-yl)oxalamide |
480452-37-7 |
EDOXABAN |
|
(R) 2-[2-(4-Amino-phenyl)-ethylamino]-1-phenyl-ethanol |
391901-45-4 |
MIRABEGRON |
|
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2 6-dione |
853029-57-9 |
LINAGLIPTIN |
|
11-Piperazinodibenzo hydrochloride [b,f][1,4]thiazepine |
753475-15-9 |
QUETIAPINE FUMARATE |
|
1-(lsocyanomethyl)sulfony)-4-methylbenzene |
738606-46-7 |
BEMPEDOIC ACID |
|
2-Butyl-1,6 dihydro-N, N,4-trimethyl-6-oxo-1[(2-(1- triphenyl methyl) methyl) -5- pyrimidine acetamide |
247257-48-3 |
FIMASARTAN |
|
(+)2 — amino-3, 6-dihydro — 4- dimethyl amino — 6 — methyl -1, 3,5-triazine |
775351-61-6 |
IMEGLIMIN HCL |
|
N-Methyl-N-({3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
477600-74-1 |
TOFACITINIB |
|
4-Amino-3-Hydroxy benzoic acid 3,5-Dichloro benzoic acid |
951395-08-7 |
TAFAMIDIS MEGLUMINE |
|
3-(Trifluoro Methyl)- 5,6,7,8-Tetrahydro-[1,2,4] Triazolo [4,3-A] Pyrazine HCl |
762240-92-6 |
SITAGLIPTIN |
|
3-Methyl-(S)-2-{ pentanoyl-[2′-(1 H-tetrazol-5-yl)-bipheny1-4-ylmethyl]-amino}-butyric acid methyl ester |
137863-17-3 |
VALSARTAN |
|
Intermediate I : 3-Methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-indole |
198479-63-9 |
BAZEDOXIFENE |
|
Intermediate II : 1-(2-(4-(Chloromethyl)phenoxy)ethyl)azepane hydrochloride |
223251-25-0 |
BAZEDOXIFENE |
*All Intermediates are available with DMF in CTD format
*Intermediates of In-Patent API’s are not offered commercially in territories where such
patents are applicable
*Intermediates available for Strategic requirements Regulated Markets.
